139 related articles for article (PubMed ID: 7682156)
1. Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival.
Taillan B; Garnier G; Schneider S; Pesce A; Fuzibet JG; Dujardin P
Cancer; 1993 May; 71(9):2881-2. PubMed ID: 7682156
[No Abstract] [Full Text] [Related]
2. Non-Hodgkin's lymphoma associated with human immunodeficiency virus: treatment with LNH 84 regimen in a selected group of patients.
Gisselbrecht C; Oksenjendler E; Tirelli U; Gabarre J; Gastaldi R; Farcet JP; Thyss A; Coiffier B; Raphael M; Lepage E
Leukemia; 1992; 6 Suppl 3():10S-11S. PubMed ID: 1376380
[No Abstract] [Full Text] [Related]
3. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.
Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS
Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399
[TBL] [Abstract][Full Text] [Related]
4. MACOP-B chemotherapy for the treatment of high-grade lymphomas in patients with HIV-1 infection.
Taillan B; Garnier G; Ferrari E; Pesce A; Vinti H; Fuzibet JG; Dujardin P
Acta Haematol; 1993; 89(1):10-2. PubMed ID: 7683165
[TBL] [Abstract][Full Text] [Related]
5. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
Cuthbert RJ; Craig JI; Ludlam CA
Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
[No Abstract] [Full Text] [Related]
6. Primary non-Hodgkin's lymphoma of the vagina.
Raspagliesi F; Ditto A; Fontanelli R; Gallino G; Massone PB; De Palo G
Haematologica; 2000 Jun; 85(6):666-7. PubMed ID: 10870129
[No Abstract] [Full Text] [Related]
7. [VEPA and ML-Y1 regimen for elderly non-Hodgkin's lymphoma].
Tanabe J; Kanamori H; Matsuzaki M; Motomura S; Mohri H; Okubo T; Maruta A; Kodama F
Nihon Ronen Igakkai Zasshi; 1994 Feb; 31(2):135-41. PubMed ID: 7517465
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
[TBL] [Abstract][Full Text] [Related]
9. Combination of chemotherapy and antiviral therapy for Epstein-Barr virus-associated non-Hodgkin's lymphoma of high grade malignancy in cases of HIV infection.
Brockmeyer NH; Pohl G; Mertins L
Eur J Med Res; 1997 Mar; 2(3):133-5. PubMed ID: 9113504
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy for advanced diffuse non-Hodgkin's lymphoma with non-cross-resistant alternating AVCP/EMLP regimens].
Yamazaki H; Ogawa M; Horikoshi N; Inagaki J; Inoue K; Nakamura T; Ueno K; Ito Y; Imajo K; Mukaiyama T
Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1404-11. PubMed ID: 3825458
[No Abstract] [Full Text] [Related]
11. Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.
Velasquez WS; McLaughlin P; Fuller LM; Allen PK; Tucker SL; Swan F; Rodriguez MA; Hagemeister FB; Cabanillas FF
Cancer; 1994 May; 73(9):2408-16. PubMed ID: 7513251
[TBL] [Abstract][Full Text] [Related]
12. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
[No Abstract] [Full Text] [Related]
13. [M-BACOD in advanced case of non-Hodgkin's lymphoma].
Itami J; Ogata H; Shimizu K; Nemoto K; Yasuda S; Yoshida H; Mikata A; Arimizu N
Gan No Rinsho; 1990 Mar; 36(4):499-504. PubMed ID: 1690824
[TBL] [Abstract][Full Text] [Related]
14. P-COMM-B induction chemotherapy in intermediate and high grade non-Hodgkin's lymphoma.
Phillips JK; Sherlaw-Johnson C; Davies JM; Clough JV; Parry H; Nash JR; Cawley JC
Leuk Lymphoma; 1995 Jun; 18(1-2):137-43. PubMed ID: 8580816
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant granulocyte colony-stimulating factor (G-CSF) in patients treated with ProMACE-CytaBOM for HIV-related non-Hodgkin's lymphoma (NHL).
Rossi G; Donisi A; Casari S; Re A; Stellini R; Cadeo G; Carosi G
Haematologica; 1998 Apr; 83(4):317-22. PubMed ID: 9592981
[TBL] [Abstract][Full Text] [Related]
16. What constitutes "improved prognosis"?
Canellos GP
J Clin Oncol; 2008 Apr; 26(12):1913-4. PubMed ID: 18421041
[No Abstract] [Full Text] [Related]
17. Non-hodgkins lymphoma.
Mead G; Woodcock J; Young C
Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
[No Abstract] [Full Text] [Related]
18. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
Gordon LI; Andersen J; Colgan J; Glick J; Resnick GD; O'Connell M; Cassileth PA
Cancer; 1995 Feb; 75(3):865-73. PubMed ID: 7530168
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma.
Walsh C; Wernz JC; Levine A; Rarick M; Willson E; Melendez D; Bonnem E; Thompson J; Shelton B
J Acquir Immune Defic Syndr (1988); 1993 Mar; 6(3):265-71. PubMed ID: 7680712
[TBL] [Abstract][Full Text] [Related]
20. Serbian lymphoma study group (SLG): the prognosis of AIDS-related non-Hodgkin's lymphoma.
Djunic I; Jevtovic DL; Ranin J; Salemovic D; Tomin D; Mihaljevic B
Biomed Pharmacother; 2008 Jan; 62(1):12-5. PubMed ID: 17629445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
